PathWave Psychiatry
PathWave Psychiatry in the Elmwood neighborhood of Berkeley, California offers Spravato (esketamine) and ketamine therapy for treatment-resistant depression, anxiety, PTSD, and mood disorders, delivered in person in a calm, private setting. Led by Dr. Sahab Yaqubi, dual board-certified in psychiatry and psychosomatic medicine and formerly an Assistant Professor at Mt. Sinai's Icahn School of Medicine, the practice combines interventional treatments with personalized, holistic care.
Alongside esketamine and ketamine, PathWave offers TMS therapy, psychiatric consultation and medication management, and psychedelic coaching, with consultations and follow-ups available via telehealth. A patient advocate team handles insurance paperwork, and the clinic works with most commercial plans including United Healthcare, Optum, Cigna, Aetna, Tricare/TriWest, and Blue Cross Blue Shield. The practice serves Berkeley, Oakland, and the greater East Bay communities.
Spravato® (esketamine)
Treatment details are based on information published by the clinic, checked in August 2026.
Monday: 9:00 AM – 5:00 PM
Tuesday: 9:00 AM – 5:00 PM
Wednesday: 9:00 AM – 5:00 PM
Thursday: 9:00 AM – 5:00 PM
Friday: 9:00 AM – 5:00 PM
Saturday: Closed
Sunday: Closed
Accepts insurance
In-network with Aetna, Anthem Blue Cross, Blue Shield of California, Cigna, Medicare, Noridian, Optum, Tricare/Triwest, UC Berkeley Student Health Insurance Program (SHIP), UMR, and UnitedHealthcare. Spravato treatment is typically covered by insurance for treatment-resistant depression and suicidal ideation.
Insurance
- Spravato (FDA-approved nasal spray) is covered by most insurance plans
- patients may only pay standard copay
Send your details to PathWave Psychiatry and they can reach out to you directly.
Reviews
Is this your clinic?
Get a featured listing to appear at the top of search results and attract more patients.
Get Featured